Mankind Pharma Q2 Results | The firm’s consumer healthcare business grew 20%, driven by key brands like Manforce, Gas-o-fast, and HealthOk, which benefited from rapid expansion in modern trade, e-commerce, and quick-commerce channels. Shares of Mankind Pharma Ltd ended at ₹2,714.40, down by ₹20.55, or 0.75%, on the BSE.
